Onconetix (ONCO) Preferred Dividend Payments (2021 - 2022)
Onconetix (ONCO) posted quarterly Preferred Dividend Payments of $96359.0 for Q1 2022, down 30.02% year-over-year from $137687.0 in Q1 2021, and down 41.3% quarter-over-quarter from $164167.0 in Q4 2021.
Onconetix (ONCO) Preferred Dividend Payments (2021 - 2022) Analysis & Trends
Onconetix (ONCO) has reported Preferred Dividend Payments for 2 consecutive years, with $96359.0 the latest figure, recorded in Q1 2022.
- In Q1 2022, Preferred Dividend Payments fell 30.02% year-over-year to $96359.0; the TTM figure through Dec 2022 stood at $96359.0 (down 84.64% YoY), while the FY2024 annual figure was $206404.0, changed N/A from the prior year.
- Preferred Dividend Payments fell to $96359.0 in Q1 2022 per ONCO's latest filing, from $164167.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $186320.0 in Q3 2021 and bottomed at $96359.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 96,359.00 |
| Dec 31, 2021 | 164,167.00 |
| Sep 30, 2021 | 186,320.00 |
| Jun 30, 2021 | 139,217.00 |
| Mar 31, 2021 | 137,687.00 |